Chondrogenesis involves the recruitment and migration of mesenchymal cells, mesenchymal condensation, and chondrocyte differentiation and hypertrophy. Multiple factors precisely regulate chondrogenesis. Recent studies have demonstrated that the redox status of chondrocytes plays an essential role in the regulation of chondrocyte differentiation and chondrogenesis. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are important factors that change the intracellular redox status. Physiological levels of ROS/RNS act as intracellular signals in chondrocytes, and oxidative stress impairs the metabolism of chondrocytes. Under physiological conditions, the balance between ROS/RNS production and elimination ensures that redox-sensitive signalling proteins function correctly. The redox homeostasis of chondrocytes ensures that they respond appropriately to endogenous and exogenous stimuli. This review focuses on the redox regulation of key signalling pathways and transcription factors that control chondrogenesis and chondrocyte differentiation. Additionally, the mechanism by which ROS/RNS regulate signalling proteins and transcription factors in chondrocytes is also reviewed.
Introduction
Chondrogenesis is the earliest stage of skeletal development. This stage involves the recruitment and migration of mesenchymal cells, mesenchymal condensation, and chondrocyte differentiation and maturation and results in the formation of cartilage and bone during endochondral bone formation [1, 2] . During endochondral ossification, chondrocyte hypertrophy is critical because cells alter the extracellular matrix and induce vascular invasion [3, 4] . This process includes the differentiation and hypertrophic differentiation of chondrocytes, which are precisely controlled by various growth factors and specific gene transcription factors through temporal and spatial activation or inhibition of cell signalling pathways. Chondrocytes may respond differently to growth factors due to their intracellular redox status. In general, reactive oxygen species (ROS) and reactive nitrogen species (RNS) are the major factors that affect intracellular redox status. Redox homeostasis is essential in maintaining the survival and function of chondrocytes. When the balance between ROS generation and elimination is destroyed, oxidative stress occurs. Oxidative stress has long been considered a significant factor in the induction of chondrocyte senescence and apoptosis in diseases such as osteoarthritis (OA) [5, 6] , and the role of ROS/RNS in the pathogenesis of osteoarthritis has become a primary concern of researchers [7, 8] . However, many recent studies have begun to concentrate on the role of physiological levels of ROS in chondrocyte differentiation and metabolism. This review mainly focuses on the redox regulation of signal transduction pathways and transcription factors that control chondrocyte differentiation.
Redox status in chondrocytes
ROS include radical species such as superoxide (O 2
•− ) and hydroxyl radicals (HO • endothelial NOS (eNOS). Chondrocytes express both eNOS and iNOS [13] . The eNOS are constitutively expressed and are stimulated by increased intracellular calcium levels to produce small amounts of NO. In chondrocytes, iNOS is expressed is in response to the presence of inflammatory cytokines [14, 15] . Calcium levels do not regulate the activity of iNOS; therefore, even in the presence of low concentrations of calcium, it may produce a significant amount of NO [16] . Nitric oxide is highly reactive with free radical species such as O 2
•−
. O 2 •− reacts with NO to produce ONOO
• , which is highly oxidizing (Fig. 1) . Chondrocytes, similar to other mammalian cells, have enzymatic and non-enzymatic antioxidant systems to eliminate ROS/RNS and maintain redox balance [17] [19] . The thioredoxin system is another crucial thiol antioxidant and is composed of thioredoxin (Trx) and thioredoxin reductase. The thioredoxin system, in cooperation with the GSH system, plays a vital role in reducing oxidized thiol-containing proteins [20] . Oxidative stress occurs when the balance between ROS/RNS production and the antioxidant defence system is destroyed. An increase in ROS production or a decrease in ROS scavenging capacity due to exogenous or endogenous metabolic changes can lead to increased intracellular ROS levels and, thus, oxidative stress. Many studies have shown that increased oxidative stress plays an essential role in pathological conditions including cancer, degenerative motor diseases, and cardiovascular diseases [21] . Under normal circumstances, physiological levels of ROS/RNS can reversibly modify biomacromolecules, which play crucial roles in regulating cell function. However, under oxidative stress, excess ROS/RNS continually attack lipids, proteins, and DNA, resulting in severe and irreversible oxidative damage. In osteoarthritis, the over-produced ROS act as second messengers to promote the expression of MMPs, which lead to cartilage degradation. Furthermore, ROS directly degrade matrix components and induce cell death [8] .
ROS/RNS functions in chondrocyte differentiation and chondrogenesis
Chondrogenesis is a dynamic and precisely regulated process. After the condensation of mesenchymal progenitor cells, these cells differentiate into chondrocytes and secrete cartilage matrix to form cartilage [22] . Cartilage is replaced by bone tissue and bone marrow to generate mature bone, a process known as endochondral ossification. Chondrogenesis is initiated by the condensation of mesenchymal stem cells, followed by the expression of chondrocyte-specific genes such as transcription factor Sox9 and genes encoding chondrocyte extracellular matrix proteins (collagen II and aggrecan) [23] . Under the control of several growth factors, chondrocytes eventually exit the cell cycle and begin to differentiate into hypertrophic chondrocytes. Late hypertrophic chondrocytes begin to express many genes associated with cartilage matrix degradation and bone formation, such as matrix metalloproteinase 13 (Mmp13) and vascular endothelial growth factor (VEGF) [24] . This process results in the degradation of the hypertrophic cartilage matrix and its replacement by bone tissue, thereby completing the process of endochondral ossification. Therefore, chondrogenesis includes different stages of chondrocyte differentiation such as mesenchymal progenitor cells condensation, cartilage formation, chondrocyte proliferation, and hypertrophic differentiation of chondrocytes.
Recent studies have revealed that ROS function as critical signalling molecules in the regulation of cell growth and differentiation [25] [26] [27] (Fig. 2) . In endochondral ossification, Nox1 and Nox4 are expressed in different regions of the growth plate. Nox4 expression in chondrocytes In growth plate, Nox1 and Nox4 are expressed in different regions. Nox4 expression in chondrocytes was observed from the resting zone to the hypertrophy region, while Nox1 expression was restricted from the proliferating zone to the prehypertrophic zone. The Nox4-derived ROS is required for the early stage of chondrocyte differentiation. Nox1 synthesizes major reactive oxygen species compared to Nox4. Therefore, chondrocytes always produce ROS throughout the endochondral ossification and emit large amounts of reactive oxygen species from the proliferative zone to the prehypertrophic zone.
was observed from the resting zone to the hypertrophy region, while Nox1 expression was restricted from the proliferative zone to the prehypertrophic chondrocyte zone [28] . Nox4 is required early in cartilage differentiation, and increasing the expression of Nox1 and decreasing the expression of Nox4 are characteristics of chondrogenesis. Therefore, in chondrocyte hypertrophy, ROS produced by Nox1 may play a major role compared to Nox4. [28, 29] . Therefore, chondrocytes always produce ROS throughout the endochondral ossification and emit large amounts of reactive oxygen species from the proliferative zone to the pre-hypertrophic zone. Importantly, it has been proved that the ROS that are generated in response to insulin stimulation are required for chondrogenic differentiation. Kim et al. demonstrated that the ROS that are required for early chondrogenic differentiation were mainly derived from Nox2 and Nox4. After the knockdown of Nox2 or Nox4 in ATDC5 cells, a chondrogenic cell line, the ROS production was decreased, and the insulin-induced chondrocyte differentiation was blocked. These results proved that ROS generated by NOXs were required for early chondrogenic differentiation [29] . Chondrocyte hypertrophy is the critical stage in chondrogenesis and endochondral ossification. During this process, the proliferating chondrocytes leave the cell cycle and enter the pre-hypertrophic differentiation phase. There is evidence that ROS play a significant role in chondrocyte hypertrophy [30] . Chondrocyte hypertrophy was inhibited by administration of the antioxidant NAC in ATDC5 cells and mice, indicating that physiological levels of ROS determine chondrocyte hypertrophy [30] . Additionally, during chondrocyte hypertrophy, the expression of NOX1, which is responsible for ROS production, was increased. These results proved that early chondrocyte differentiation and hypertrophy was stimulated by the expression of ROS-producing genes, such as NOXs. As a result, the intracellular ROS that were generated by NOXs can alter the cellular response to growth factor cytokines by mediating the redox-sensitive signalling pathways and expression of transcription factors during chondrogenesis [31] . Similar to ROS, NO has been proved to participate in endochondral ossification. Teixeira et al. showed that excess NO promotes hypertrophic differentiation and apoptosis of chondrocytes in chickens [32, 33] . Wang et al. suggest that the basal levels of NO that are generated by iNOS are required for chondrogenesis [34] .
Recent evidence convincingly argues that these ROS/RNS play essential roles in numerous physiological and pathological processes [35] . The central mechanism of the redox regulation of proteins is oxidative modification [36] . The mechanism of redox regulation of proteins is through various types of oxidative modifications on the redox-sensitive sites of proteins, and the result may be the activation or inactivation of protein functions. ROS/RNS can directly oxidize various redox-sensitive amino acids, with cysteine (Cys) being the main target molecule. Mild oxidative stress can induce cysteine modifications such as reversible [37, 38] disulfide bond formation [39] and S-nitrosylation [40, 41] . These reversible redox post-translational modifications have proved to be essential signals in many cells.
In contrast, oxidative stress promotes the modification of sulfenic, sulfinic and sulfonic acids in proteins, which are destructive to protein function [42] (Fig. 3) . To date, it has been demonstrated that redox signalling can control chondrogenesis by regulating transcription factors and signal transduction pathways. ROS/RNS can modulate the ability of transcription factors to bind to DNA by modifying the Cys residues contained in the DNA-binding sites of transcription factors [39] . Additionally, oxidative modification plays a reversible regulatory role in the function of many protein tyrosine phosphatases, which can regulate chondrogenesis and chondrocyte functions (Fig. 4) .
Redox control of signal pathways involved in chondrocyte differentiation and chondrogenesis

MAPK signalling pathway
The MAPK family includes three significant members, ERK, JNK and p38 MAPK. Studies have shown that ERK and p38 MAPK are required for chondrocyte survival and endochondral ossification. The p38 MAPK has been demonstrated to be activated in response to and to mediate the effects of several growth factors that are essential for chondrocyte differentiation and function, including TGF-β and bone morphogenetic proteins (BMP) [43] [44] [45] . During chondrogenic differentiation in vitro, the p38 MAPK pathway regulates the expression of collagen II and aggrecan, proteoglycan synthesis and cartilage nodule formation [46] . Moreover, p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation [47] . Consistent with p38, ERK participates in the terminal differentiation of chondrocytes. In mice with ERK1/2 deleted in hypertrophic chondrocytes, the process of endochondral ossification is impaired [48] .
It has been reported that elevated ROS during chondrocyte hypertrophy have been found to activate ERK and p38 MAPK. Furthermore, MEK and p38 inhibitors suppressed the H 2 O 2 -induced hypertrophic gene expression, indicating that ROS transduce differentiation signals by activating the ERK and p38 MAPK pathways in chondrocytes [30] . However, the mechanism of how ROS activates ERK1/2 and p38 MAPK during chondrogenesis is unclear. In other cells, S-nitrosylation or glutathionylation of Ras has been known to directly activate the protein and initiate the Ras-Raf-MEK/ERK cascade [49, 50] . The p38 MAPK has been proved to be activated by apoptosis signal-regulated kinase 1 (ASK1) under oxidative stress. When ROS oxidizes two cysteine residues in the redox centre of thioredoxin, ASK1 is activated, causing the formation of intramolecular disulfide bonds between Cys-32 and Cys-35 [51, 52] . Evidence that the ROS/ASK1/p38 MAPK pathway transmits differentiation signals in other cells may suggest a mechanism for ROS activation of p38 MAPK in chondrocytes [53] .
PI3K-Akt signalling pathway
Studies have demonstrated that PI3K plays a vital role in chondrogenesis and chondrocyte differentiation [4, 54, 55] . It has been shown that the activation of the PI3K-Akt pathway inhibits the transition in chondrocytes from proliferation to hypertrophic differentiation. On the other hand, the PI3K-Akt signalling pathway promotes the terminal differentiation of chondrocytes [54, 56] . In addition to redox regulation of phosphatases, ROS/RNS can also directly oxidize protein kinases (PI3K and Akt). This oxidative modification results in the downregulation of the PI3K/Akt signal [57] .
In chondrocytes, insulin-like growth factor 1 (IGF-1) activates the IGF-1 receptor (IGF-1R), which induces activation of the insulin receptor substrate 1 (IRS-1) through tyrosine phosphorylation and, subsequently, activates the PI3K/Akt pathway, leading to increased aggrecan synthesis and collagen II expression. During early chondrogenesis, suppression of ROS generation by knockdown of Nox2 or Nox4 inhibited insulin-induced Akt phosphorylation [29] . This indicates that the Nox-derived ROS are required for Akt phosphorylation during early chondrogenesis. However, Yin et al. showed that oxidative stress also inhibited IGF-1-induced Akt phosphorylation in osteoarthritis chondrocytes [58] . Taken together, these results demonstrate that redox status in chondrocytes can alter intracellular signal transduction in response to growth factors and cytokines.
The PI3K/Akt signalling pathway is sensitive to redox modifications, and the redox regulation of PI3K/Akt is mainly conducted by oxidative modification of Cys-dependent phosphatases (CDPs) and protein kinases. [59, 60] . CDPs that regulate PI3K/Akt signalling include PI3-phosphatase, PTEN, and PTPases. It is known that ROS can oxidize Cys residues in CDPs to cause the loss of phosphatase activity. This modification activates the PI3K/Akt signalling pathway. For example, oxidative inactivation of PTEN by S-nitrosylation of Cys residues is an important mechanism of oxidative stress-induced PI3K/Akt activation [61] .
mTOR signalling pathway
The mTOR signal pathway has been shown to be essential for chondrocyte proliferation and endochondral ossification [62] [63] [64] . It has been demonstrated that mTORC1 activity declines during chondrocyte differentiation in vitro and in vivo. Activation of the mTOR signalling pathway in chondrocytes promotes growth and proliferation but prevents the terminal differentiation of hypertrophic chondrocytes [65] . It is proved that the inhibition of mTOR is required for chondrocyte hypertrophy. Our previous study showed that inhibition of mTOR promotes hypertrophic differentiation in the pellet culture model [3] .
It has been proved that Nox-derived ROS are required for Akt phosphorylation during early chondrogenesis. We hypothesized that ROS-induced Akt phosphorylation activates mTOR during early chondrogenic differentiation. In addition, physiological ROS levels are known to activate the mTOR signalling pathway in most cells [66] [67] [68] . The mechanism by which ROS activate mTOR is the Cys oxidation of Ras homologue enriched in brain (Rheb) and regulatory-associated protein of mTOR (Raptor) [66, 69, 70] . It has been found that the ROS regulate the Raptor-mTOR complex to control the ribosomal protein S6 kinase (S6K1), an effector of Raptor-mTOR. The ROS activate the Raptor-mTOR pathway through destabilization of the Raptor-mTOR interaction. In contrast, a reducing reagent inhibits this pathway by stabilization of the Raptor-mTOR interaction [66] .
Importantly, further experiments need to be performed to verify the specific mechanism of ROS function on the mTOR signalling pathway during chondrogenesis. Furthermore, numerous studies have demonstrated that oxidative stress activates autophagy by inhibiting the mTOR signalling pathway to protect chondrocytes from apoptosis [71, 72] . However, the specific mechanism of oxidative stress in inhibiting mTOR activity needs to be further studied in chondrocytes.
cGMP signalling pathway
It has been demonstrated that cGMP plays an important role in chondrocyte terminal differentiation [33] . The increase in cGMP concentration may lead to the activation of phosphodiesterases (PDE), cGMP-regulated ion channels (ICH) and cGMP-dependent kinases (cGK). In particular, cGKII has been shown to play an essential role in endochondral bone formation [73, 74] . Possible downstream pathways include the inhibition of nuclear translocation of the transcription factor Sox9 and the repression of FGF signalling and ERK activation through Raf1 [75] .
Teixeira et al. demonstrated that the expression of NOS and the generation of NO enhanced alkaline phosphatase and collagen type X expression by increasing cGMP concentration [33] . Nitric oxide could bind to the haem-containing soluble protein guanylate cyclase, causing increased enzymatic activity and formation of cGMP. Depending on the cell type, the increase in cGMP concentration may lead to activation of phosphodiesterases, cGMP-regulated ion channels and cGMP-dependent kinases (cGKs) [76] .
Redox control of transcription factors involved in chondrocyte differentiation and chondrogenesis
HIF-1α
Hypoxia-inducible factor 1 alpha subunit (HIF-1α) is a crucial transcription factor for chondrogenesis and chondrocyte differentiation. Specific deletion of HIF-1 within chondrocytes led to the death of hypoxic chondrocytes and promoted chondrocyte-proliferation, resulting in delayed hypertrophy in the growth plate [77] . Cartilage and growth plates are avascular tissues. Research has proved that HIF-1α is required for the survival of chondrocytes in the hypoxic region of the growth plate [78] . HIF-1α plays a non-redundant and critical role in the differentiation of mesenchymal cells into chondrocytes. HIF-1α was found to enhance the BMP2-induced chondrogenic expression of Sox9 and downstream markers and inhibit the osteogenic expression of Runx2 and downstream markers in vitro [79] . Lack of HIF-1α in limb bud mesenchyme caused a remarkable delay in chondrogenesis [80, 81] .
The HIF-1α protein is oxygen-sensitive through oxygen-dependent hydroxylation of specific residues within its amino acid sequence. In normoxia, the oxygen-dependent degradation domain (ODDD) of HIF-1α is hydroxylated by HIF prolyl 4-hydroxylases [82] . The E3 ubiquitin ligase Von Hippel-Lindau (VHL) binds to hydroxylated HIF-1α. Then, HIF-1α degrades via the ubiquitylation pathway [83, 84] . Under hypoxic conditions, HIF-1α is not hydroxylated. HIF-1α can then freely migrate to the nucleus and bind to the β subunit, acting as a transcription factor. ROS/RNS exert different effects on the HIF-1α protein in normoxia and hypoxia. In normoxia, ROS/RNS production can stabilize HIF-1α [85, 86] . Reducing ROS/RNS levels by antioxidants or reducing active oxygen producing enzyme activity can reduce HIF-1α expression [85, 87, 88] . It has been shown that ROS/RNS can stabilize HIF-1α in normoxia through multiple pathways [89] . Accumulation of ROS can lead to the inactivation of PHD, leading to the stabilization of HIF-1α [90] . Additionally, direct oxidative modifications such as S-nitrosylation of HIF or VHL proteins have been shown to lead to stabilization of HIF-1α [91, 92] . Under hypoxic conditions, both ROS and RNS inhibit HIF-1α DNA-binding activity and HIF-1α accumulation. Kazuo Yudoh et al. found that IL-1β and H 2 O 2 could promote the expression of HIF-1α mRNA and protein in human articular chondrocytes in vitro under hypoxia (O 2 < 6%) [93] . Under hypoxic conditions, inhibitors of PI3K and p38 MAPK reduced the protein levels of IL-1β-induced HIF-1α mRNA expression. However, further in-depth and systematic studies are required to determine how ROS/RNS regulate the turnover and transcriptional activity of HIF-1α in chondrogenesis.
AP-1
The c-fos and c-Jun proteins form the activator protein 1 (AP-1) complex. Some studies have shown that the AP-1 family plays a significant role in the hypertrophic differentiation of chondrocyte [94] . As a transcription factor, AP-1 activates genes required for the differentiation of various chondrocytes. Furthermore, recent studies have shown that AP-1 could directly interact with transcription factors such as Sox9 and Runx2, which are crucial chondrogenic differentiation factors, thereby promoting the marker gene for hypertrophic chondrocyte differentiation [94] . Nitric oxide may suppress the DNAbinding activity of AP-1 through S-glutathionylation. In the presence of the physiological sulfhydryl glutathione, nitric oxide modifies the two cysteine residues contained in the DNA-binding module of c-Jun selectively and distinctly. The formation of a mixed disulfide bond with glutathione inhibited the binding of AP-1 to DNA [95] . Furthermore, the intracellular level of AP-1 can be regulated by redox-mediated mechanisms at the levels of transcription and protein turnover. For example, in bovine articular chondrocytes, TNF-α and essential fibroblast growth factor (bFGF) were found to induce ROS production through an NADPH oxidase enzyme complex, resulting in the upregulation of c-fos expression [96] . Similarly, ROS can regulate IL-1β induction of c-fos expression in the articular chondrocytes [97] .
NK-κB/p65
Transcriptional targets of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) have been recognized as key developmental signalling mediators that regulate endochondral ossification. The involvement of NF-κB/p65 as an indispensable factor during chondrogenic development has been studied in the context of mature chondrocytes. NF-κB/p65 has been identified as a transcription factor for BMP2 and Sox9 in mature chondrocytes during endochondral ossification [98] [99] [100] . Moreover, it has been proved that activation of p65 promotes the early stage of chondrocyte differentiation during endochondral ossification [101] .
The function of NF-κB can be activated or inhibited at various levels of the activation pathway through different redox-mediated mechanisms. In the nucleus, direct oxidation of Cys in the DNA-binding domain can hinder NF-κB DNA binding activity. In the cytosol, activation of NF-κB can be regulated by phosphorylation of NF-κB itself or phosphorylation of its inhibitor IκB. Under normal conditions, NF-κB and IκB form complexes that are sequestered in the cytosol. Increased ROS can directly activate IκB kinase (IκK) by redox-modification of IκK or can indirectly activate IκB kinase (IκB) by activating Akt and, subsequently, can phosphorylate and activate IκK [102] . Activated IκK phosphorylates IκB and releases active NF-κB from the complex for translocation to the nucleus [101] . Clancy et al. proved that nitric oxide and its derivatives could regulate cytokine-induced NF-κB activation in chondrocytes. Their results demonstrated that nitric oxide sustains NF-κB signalling in chondrocytes, most likely via peroxynitrite. Persistent activation of NF-κB signalling in chondrocytes further promotes and amplifies the transcription of inflammatory cytokines, growth factors and metalloproteinases [103] .
Conclusion
Chondrogenesis is a continuous and dynamic process that is regulated by many growth factors. The intracellular redox status affects the response of chondrocytes to extracellular stimulation. Our review shows that the redox status controls chondrocyte differentiation and chondrogenesis as an endogenous regulator of signalling kinases and transcription factors. Although ROS/RNS have been studied extensively in other cells as signalling molecules that affect cellular processes, they have not been sufficiently investigated in chondrocytes. The specific state of redox levels in the articular cartilage and growth plate regions remains unclear. Similarly, the detailed mechanisms of how ROS regulate signalling pathways has not been studied in detail in chondrocytes and growth plates.
